| Up
2004D-0283:
WAIVERS OF IN VIVO DEMONSTRATION
OF BIOEQUIVALENCE OF ANIMAL DRUGS IN SOLUBLE POWDER ORAL DOSAGE
FORM PRODUCTS AND TYPE A MEDICATED ARTICLES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| File(s)
|
| Remarks
|
|
|
|
|
|
| GDL1
|
| 08/03/2004
|
| 08/03/2004
|
| Federal
Government
|
| Guidance
|
|
|
|
|
|
|
| pdf,
doc
|
|
|
|
|
|
| Signature:
|
| Guidance
|
|
|
|
|
|
|
|
| NAD1
|
|
|
| 08/02/2004
|
| FDA
|
| FDA
|
| 08/03/2004
|
| 46553-46555
|
| 10/15/2004
|
| pdf
|
|
|
|
|
| Signature:
|
| Jeffrey Shuren
|
|
|
|
|
| EXT1
|
| 09/15/2004
|
| 09/14/2004
|
| Association
|
| Animal Health
Institute (AHI)
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Alexander S. Mathews
| |
Page last updated March 16, 2004 kk |
